Atorvastatin, Rosuvastatin, and Simvastatin Are Associated wit...New England Journal of Medicine, 8 hours ago |
46 images for atorvastatin | ||||
Benefits of statins for prevention of heart disease questionedCholesterol-lowering drugs heavily promoted to prevent strokes and heart attacks Statins such as atorvastatin (Lipitor), Rosuvastatin (Crestor) and simvastatin (Zocor) are among the widely used prescription drugs. More than 38 million prescriptions ... CBC, 2 weeks ago
Statins benefit questioned for heart disease prevention Jun 5, 2013 10:32 PM ET Cholesterol-lowering statins are heavily promoted for heart patients but research is calling into question their use as a preventive medicin
CBC, 1 week ago
New Study Suggests Statins May Blunt Benefits Of Exercise
Forbes.com, 3 weeks ago
|
Amarin (AMRN) Reports Significant Additional Data from Vascepa Phase 3 ANCHORpharmacokinetic data showing the lack of drug-drug interaction when Vascepa was administered with atorvastatin, a commonly prescribed cholesterol lowering medication pharmacokinetic data showing the lack of drug-drug interaction when Vascepa was ... Street Insider, 2 weeks ago
Amarin Announces Additional Effects Of Vascepa(R) On Lipoprotein Particle Concentration From The ANCHOR Study Presented At The National Lipid Association 2013 Annual Scientific Sessions
TheStreet.com, 2 weeks ago
|
Product showcase, June 2013New approvals FDA has approved atorvastatin/ezetimibe (Liptruzet—Merck) for the treatment of elevated LDL cholesterol levels in patients with primary or mixed hyperlipidemia as an adjunct to dietary changes and to reduce cholesterol in patients ... Pharmacist.com, 2 weeks ago
FDA Approves Merck's LIPTRUZET? ezetimibe and atorvastatin, a New Product That Can Help Powerfully Lower LDL Cholesterol
Pharmacy Choice, 1 month ago
FDA Approves Merck's LIPTRUZET (Ezetimibe and Atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol
AAPS Pharmceutica, 1 month ago
FDA Approves Liptruzet (ezetimibe and atorvastatin), a to Help Lower LDL Cholesterol
Diagnostic & Invasive Cardiology, 1 month ago
|
Generic atorvastatin brings £350m in savingsGeneric versions of atorvastatin, which was previously only available from Pfizer as Lipitor, have saved the NHS more than £350m in 12 months, according to figures from the British Generic Manufacturers Association. The drug became available as a ... PJ Online, 1 month ago
Atorvastatin saved NHS £350m in 12 months after expiry of Lipitor patent
Pharmacy.Biz, 1 month ago
Lipitor generics help NHS save £1m per day
Pharma Times, 1 month ago
|
Ranbaxy reinforces dedication to provide safe, quality medications globallyRanbaxy Laboratories, Ltd., which was involved in a recall of Atorvastatin, the generic form of Lipitor, issued a press release to address certain conduct of the past.In a press release dated May 22, Ranbaxy, Ltd., which is Examiner.com, 3 weeks ago
Ranbaxy: Looking Under the Rock
Corante, 1 month ago
US marketing to get tough for Ranbaxy Laboratories
Financial Express, 1 month ago
Ranbaxy Q1 profits fall by 90%
Pharmacy News, 1 month ago
|
Ranbaxys Q4 performance remains volatileThe company has only a 2% market share of atorvastatin, the generic of Lipitor; the market share eroded after the drug was recalled temporarily. Economic Times, 1 month ago
Lupin outshines Ranbaxy on strong US, domestic sales
Smart Investor, 1 month ago
More from: , Smart Investor...and 1 other sources
|
FDA Approves Combination Of Ezetimibe And AtorvastatinThe FDA has approved a new combination drug from Merck Merck Merck said the new drug (pronounced "LIP-true-zett") would be commercially available starting next week. Liptruzet will be available as a once-daily tablet combining 10 mg of ezetimibe ... Forbes.com, 1 month ago
Liptruzet Approved By FDA To Cut Cholesterol, Despite Criticism By Cardiologists
Medical News Today, 1 month ago
Surprise as Merck & Co cholesterol combo gets FDA OK
Pharma Times, 1 month ago
FDA approves new cholesterol-lowering pill, but we say skip it
Consumer Reports, 1 month ago
More from: CNBC, Reuters UK...and 15 other sources
|
Opinion/decision on a Paediatric Investigation Plan (PIP): -, amlodipine (besylate) / atorvastatin (calcium), Therapeutic area: Cardiovascular diseases/Endocrinology, -gynacology-fertility-metabolismprevention of cardiovascular events in hypertensive patients and diabetes mellitus type 2 patients with multiple risk factors for cardiovascular disease treatment of concomitant angina and dyslipidaemia Treatment of concomitant hypertension European Medicines Agency, 1 month ago
|
Ranbaxy resumes supply of Atorvastatin tablets to US marketRanbaxy Pharmaceutical, the US subsidiary of Ranbaxy Laboratories has resumed the supply of Atorvastatin calcium tablets that includes 10mg, 20mg, 40mg and 80mg dosage strengths to the US market. ''Ranbaxy, remains committed to patient safety and delivering ... Myiris, 2 months ago
More from: , Money Control...and 4 other sources
|